A safe, high-quality pharmaceutical or health product can fail to reach patients due to misjudged regulatory pathways, incomplete technical dossiers, or unnavigated local registration requirements. In markets like Nigeria, products must navigate strict NAFDAC requirements for quality, safety, and efficacy, alongside separate trademark and standards registrations.